Controlled metabolic accelerator: new drug for treating fatty liver disease

| Fatty liver | News | Treatments

Controlled metabolic accelerator: new drug for treating fatty liver disease

HU6 is a novel oral drug that reduces liver fat and body weight through controlled metabolic acceleration, showing promising results in clinical trials compared to placebo.

| Diseases | Fatty liver | News

Fatty liver disease and alcohol tolerance

A large study shows that daily alcohol consumption, even in small amounts, worsens liver fibrosis in patients with metabolic liver disease.

| Fatty liver | News | Treatments

Vitamin E for fatty liver disease

A large study reveals that vitamin E can reduce liver fibrosis and improve liver health in patients, reinforcing its therapeutic value alongside diet and exercise.

| Autoinmune hepatitis | News | Treatments

Infliximab treatment for autoimmune hepatitis

Infliximab shows positive results in autoimmune hepatitis resistant to conventional therapies, improving liver function in most patients and representing a potential future treatment option.

| Fatty liver | Health | News

Menarche and fatty liver

Women with early menarche show a higher risk of fatty liver disease. Later onset lowers this risk, highlighting the importance of monitoring weight and liver health.

| Health | Healthy nutrition | News

New drug for the treatment of obesity

MariTide, a new drug for obesity, delivers significant weight loss with a single monthly injection, while also reducing blood pressure and glucose levels in patients.

| Fatty liver | Healthy nutrition | News

Manganese and fatty liver

A study links elevated blood manganese levels with a higher risk of liver disease. Controlling dietary intake and workplace exposure is crucial to reduce this risk and protect health.

| Health | News

Weight loss drugs: Semaglutide vs Tirzepatide

A comparative study found that tirzepatide outperforms semaglutide for weight loss, achieving greater reductions in body weight, waist circumference, and blood pressure, with similar side effects in both treatments.

| News | Treatments

Treatment of pruritus in primary biliary cholangitis

Linerixibat, a bile acid transport inhibitor, has shown significant benefits in the treatment of pruritus in primary biliary cholangitis, reducing itching and improving sleep with minimal side effects.

| Fatty liver | News | Treatments

Research of a new drug for fatty liver

A promising new treatment for fatty liver disease has outperformed existing medications like Ozempic and Mounjaro in reducing liver fat, according to a recent study presented at a major liver disease conference.